<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">FMAR</journal-id><journal-title-group><journal-title>Forensic Medicine and Anatomy Research</journal-title></journal-title-group><issn pub-type="epub">2327-4115</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/fmar.2022.104007</article-id><article-id pub-id-type="publisher-id">FMAR-120683</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Pathological Lung Lesions of COVID-19 and Opioid Use Disorder: A Post-Mortem Lung and Toxicology Examination of 43 Decedents
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alexis</surname><given-names>Bloom</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Austyn</surname><given-names>Colter</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Max</surname><given-names>Jacobsen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Domnique</surname><given-names>Battles</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tamara</surname><given-names>Alberston</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>George</surname><given-names>Sandusky</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Pathology, IUPUI, Indianapolis, IN, USA</addr-line></aff><aff id="aff2"><addr-line>Marion County Coroner’s Office, Indianapolis, IN, USA</addr-line></aff><pub-date pub-type="epub"><day>26</day><month>10</month><year>2022</year></pub-date><volume>10</volume><issue>04</issue><fpage>65</fpage><lpage>76</lpage><history><date date-type="received"><day>29,</day>	<month>July</month>	<year>2022</year></date><date date-type="rev-recd"><day>23,</day>	<month>October</month>	<year>2022</year>	</date><date date-type="accepted"><day>26,</day>	<month>October</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The COVID-19 pandemic has continued from 2019 to current times, exacerbating existing epidemics since its beginning. Pathologic lung lesions in acute cases have consisted of hyaline membrane disease and microthrombi. More severe cases have pathologic lesions of alveolar and bronchiolar epithelial necrosis, lymphocytic interstitial infiltrate, and peribronchiolar and perivascular lymphocytic infiltrate. The opioid epidemic is one epidemic exacerbated by COVID-19. Those with opioid use disorder (OUD) are more likely to have compromised lung function, of which infection with the SARS-CoV-2 virus can worsen. The combined symptoms lead to an increased risk of overdose. In addition to anatomical risks, those with OUD require person-to-person contact to obtain opioids. This enhances the spread of COVID-19 and increases the risk of acquiring the disease. Pathological findings in those with chronic OUD can contain fluorescing talc powder with multinucleated giant cells and granulomas in the lung tissue. Twenty-one positive cases and twenty-two negative cases were collected from COVID-19 suspicious decedents in 
  Marion County Coroner’s Office. Toxicology screens and COVID-19 RT-PCR tests were run on each of the 43 decedents. Microscopic evaluation was done by hematoxylin and eosin (H &amp; E) and Masson’s Trichrome stains. The age range of those collected was 3 to 81 years. The ethnicities were 1 Asian, 8 African American, 1 Cuban, 3 Hispanic, 29 Caucasian, and 1 unknown. The male to female ratio was 3.8:1. The histological features found in this study were alveolar and bronchiolar epithelial necrosis, lymphocytic interstitial infiltrates, perivascular and peribronchiolar lymphocytic infiltrate, fibrosis, microthrombi, and hyaline membrane. Fluorescing talc was seen in 5 cases with granulomas and multinucleated giant cells. Toxicology reports showed 11 
  drug-related deaths, with cocaine, methamphetamine, alcohol, fentanyl, morphine, acetyl fentanyl, and sertraline as the causative agents.
 
</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd> Pathology</kwd><kwd> Talc</kwd><kwd> Lung</kwd><kwd> Opioids</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Since 2019, the novel virus COVID-19 has restructured the daily lives of people throughout the world. From mask mandates to stay-at-home orders, businesses and hospitals have implemented many new rules to keep visitors and employees safe. The chronic disease form has caused death in multiple patients caused by severe alveolar and bronchiolar necrosis with lymphocytic interstitial infiltrate [<xref ref-type="bibr" rid="scirp.120683-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref5">5</xref>]. This damage is caused by the high affinity of SARS-CoV-2 for bronchiole respiratory epithelium on the ACE2 receptor [<xref ref-type="bibr" rid="scirp.120683-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref8">8</xref>]. Patients with the acute form are identified through hyaline membrane disease and microthrombi in the pulmonary vasculature [<xref ref-type="bibr" rid="scirp.120683-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref5">5</xref>].</p><p>The pathological findings and transmissibility of the virus have exacerbated the symptoms of the opioid epidemic as well. People with opioid use disorder (OUD) are more likely to develop severe COVID-19 disease and contract the virus [<xref ref-type="bibr" rid="scirp.120683-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref10">10</xref>]. OUD reduces lung function, which causes more exacerbations from COVID-19 and an increased risk of overdose [<xref ref-type="bibr" rid="scirp.120683-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref10">10</xref>]. In addition, people with OUD are more likely to have social contact to acquire opioids [<xref ref-type="bibr" rid="scirp.120683-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref12">12</xref>]. The required social contact increases the spread among those with OUD and subsequent social isolation increases the chance of an overdose not being noticed [<xref ref-type="bibr" rid="scirp.120683-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref14">14</xref>]. Pathological findings in those with OUD may have fluorescing talc in the lung tissue.</p><p>This study analyzed the lung pathology of 43 COVID-19 positive and COVID-19 negative decedents from ages 3 to 86 (<xref ref-type="table" rid="table1"><xref ref-type="table" rid="table">Table </xref>1</xref>). Samples from these patients were collected in partial pulmonary autopsies. Toxicology reports were obtained for each decedent from the Marion County Coroner’s Office and logged into the patient’s medical history (<xref ref-type="table" rid="table2"><xref ref-type="table" rid="table">Table </xref>2</xref> and <xref ref-type="table" rid="table3"><xref ref-type="table" rid="table">Table </xref>3</xref>). The decedents were not seen in a hospital setting before autopsy in concordance with the study. Pathological analysis was done using H &amp; E and Masson’s Trichrome stains.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>The study was run from April 1, 2020, to March 1, 2021, with IRB approval obtained on March 30, 2020. Marian County Coroner’s Office investigates deaths meeting the following criteria: “1) sudden death of a healthy child; 2) physician is unable to state cause of death, after careful review of medical chart, or the deceased does not have a physician; 3) known or suspected homicide; 4) known of suspected suicide; 5) related to or following known suspected self-induced or</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1"><xref ref-type="table" rid="table">Table </xref>1</xref></label><caption><title> Pathological findings for the 43 COVID-19 positive and COVID-19 negative decedents. “X” marks indicate the presence of the finding for that column</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Patient Number</th><th align="center" valign="middle" >Pneumonia</th><th align="center" valign="middle" >Thrombi</th><th align="center" valign="middle" >Necrosis/Damage</th><th align="center" valign="middle" >Fibroplasia (Trichrome)</th><th align="center" valign="middle" >Hyaline Membrane</th><th align="center" valign="middle" >Talc</th><th align="center" valign="middle" >Disease Stage</th><th align="center" valign="middle" >COVID-19 Status</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >MF Interstitial</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >MF Interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >MF Interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >F Interstitial, MF Bronchiolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >MF/Diffuse Interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >F Interstitial, F Fibrinous</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >F Interstitial</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >Bronchopneumonia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar, General</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >F Interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >F Interstitial</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >F Interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >F Interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >Granulomatous</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >24</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >25</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >26</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >27</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >28</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >29</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >30</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Mild Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >31</td><td align="center" valign="middle" >Diffuse Interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >32</td><td align="center" valign="middle" >Diffuse Interstitial</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >33</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >34</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >35</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bronchiole Epithelial, Alveolar</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >36</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Bronchiole Epithelial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >37</td><td align="center" valign="middle" >F bronchiolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Alveolar</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >38</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >39</td><td align="center" valign="middle" >F bronchiolar, F interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >40</td><td align="center" valign="middle" >F interstitial, Peribronchiolar</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >Bronchiole epithelial</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >41</td><td align="center" valign="middle" >Focal Interstitial</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >42</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >x</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >43</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Pulmonary Hemorrhage</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Positive</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2"><xref ref-type="table" rid="table">Table </xref>2</xref></label><caption><title> <xref ref-type="table" rid="table">Table </xref>of decedents whose cause of death was drug-related based on toxicology results. Medical history was collected by the Marion County Coroner’s Office from the decedent’s family members. Patients were not seen in the hospital before autopsy</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Patient Number</th><th align="center" valign="middle" >Age</th><th align="center" valign="middle" >Decedent Sex</th><th align="center" valign="middle" >Race</th><th align="center" valign="middle" >Medical History</th><th align="center" valign="middle" >Talc</th><th align="center" valign="middle" >Cause of Death</th><th align="center" valign="middle" >COVID-19 Status</th></tr></thead><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Shortness of Breath/Cough White</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Acute Cocaine Intoxication</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Flu Symptoms</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Intoxication Methamphetamine</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >Tired/Flu Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications Chronic Alcoholism</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Stent Placement</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Fentanyl &amp; Morphine</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Kidney Stones</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Acetyl fentanyl Intoxication</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Myocardial Infarction</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Fentanyl Intoxication</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Fentanyl Intoxication</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >24</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications Chronic Ethanol</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >27</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Fever Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of Acute Methamphetamine Intoxication</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >28</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Cuban</td><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Toxic Effects Sertraline</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >30</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Fentanyl and Ethanol Intoxication</td><td align="center" valign="middle" >Negative</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3"><xref ref-type="table" rid="table">Table </xref>3</xref></label><caption><title> <xref ref-type="table" rid="table">Table </xref>of decedents whose cause of death was non-drug related based on toxicology results. Medical history was collected by the Marion County Coroner’s Office from the decedent’s family members. Patients were not seen in the hospital before autopsy</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Patient Number</th><th align="center" valign="middle" >Age</th><th align="center" valign="middle" >Decedent Sex</th><th align="center" valign="middle" >Race</th><th align="center" valign="middle" >Medical History</th><th align="center" valign="middle" >Talc</th><th align="center" valign="middle" >Cause of Death</th><th align="center" valign="middle" >COVID-19 Status</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >Diabetes/Fever</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Diabetes/Coughing</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Atherosclerotic Heart Disease</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Hypertension/Seizures</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >Shortness of Breath</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Atherosclerotic Heart Disease</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Diabetes/Vomiting</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Asthma/High Blood Pressure</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Hypertensive Heart Disease</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >N/A</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Shortness of Breath</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Flu Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Hispanic</td><td align="center" valign="middle" >Flu Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Acute Fibrinous Pneumonia</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Flu Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Interstitial Pneumonia</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >86</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Acute Pneumonia</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Cardiovascular Disease</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Organizing Granulomatous Pneumonia</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID, Diabetes</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >Pneumonia</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Granulomatous Pneumonia</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >25</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >Fever Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Gastrointestinal Hemorrhage</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >26</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Pulmonary Hemorrhage</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >29</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Asian</td><td align="center" valign="middle" >Flu Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Ketoacidosis</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >31</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Flu Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >32</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >33</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Black</td><td align="center" valign="middle" >ADHD</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Gunshot Wound Head</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >34</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Seizure Disorder</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Hanging</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >35</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Hispanic</td><td align="center" valign="middle" >Depression</td><td align="center" valign="middle" >x</td><td align="center" valign="middle" >Multiple Blunt Force Injuries</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >36</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >37</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >38</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >None</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >39</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Test positive 3 months prior</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Gunshot Wound Head</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >40</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >Hispanic</td><td align="center" valign="middle" >Flu Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Complications of COVID</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >41</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Mild Interstitial Pneumonia</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >42</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Flu Symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Pending</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >43</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >White</td><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Gunshot Wound Chest</td><td align="center" valign="middle" >Positive</td></tr></tbody></table></table-wrap><p>criminal abortion; 6) following an accident or injury primary or contributory, either old or recent; 7) accidental poisoning (food, chemical, drug, therapeutic agents); 8) occupational disease or hazard; 9) all deaths of unidentified persons; 10) person in the custody of the state (incarcerated, foster care, adult protective services); 11) has died by casualty” [<xref ref-type="bibr" rid="scirp.120683-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref16">16</xref>]. Of these cases, decedents were chosen for the study if the deputy coroner’s report showed a history of respiratory distress, fever, cough, or viral infection within the past 7 days. This involved 43 cases. Case limits were not set for this study. All cases marked as COVID-19 suspicious were included. Informed consent was collected from the family members of the decedent.</p><p>Marion County Coroner’s Office performed partial pulmonary autopsies on decedents marked as COVID-19 positive or COVID-19 suspicious. Blood samples were collected and tested for SARS-CoV-2 by the Indiana Department of Health using RT-PCR methodology. Toxicology screens were run for 30 analytes by Marion County Forensics Department according to their guidelines and used to help determine the cause of death. Lung samples were observed grossly and microscopically. Light microscopic analysis was recorded with H &amp; E and Masson’s Trichrome stains. The pathology read was scored as follows: alveolar and bronchiolar epithelial necrosis, lymphocytic interstitial infiltrates, perivascular and peribronchiolar lymphocytic infiltrate, fibrosis, microthrombi, and hyaline membrane disease, and talc powder.</p></sec><sec id="s3"><title>3. Results</title><p>The age range of decedents was 3 to 81 years. The ethnicities were 1 Asian, 8 African American, 1 Cuban, 3 Hispanic, 29 Caucasian, and 1 unknown. The male-to-female ratio was 3.8:1 (<xref ref-type="table" rid="table1"><xref ref-type="table" rid="table">Table </xref>1</xref>). Twenty-one patients tested positive for COVID-19 and twenty-two patients tested negative for COVID-19.</p><p>The pathology found in the 21 COVID-19 positive cases mainly consisted of multifocal or diffuse alveolar necrosis and bronchiolar respiratory epithelial necrosis. Lymphocytic infiltration was also seen throughout the lung interstitium, indicating pneumonia (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In some cases, the lymphocytic infiltration was seen in the peribronchiolar and perivascular interstitium instead (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Few cases had the alveolar spaces filled with macrophages. Fibroplasia was noted in decedents with severe COVID-19 (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Six acute cases contained hyaline membrane and microthrombi in multiple pulmonary vasculatures (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Two cases were found to have granulomatous pneumonia with talc powder characterized by focal granulomas and multinucleated giant cells. The talc powder was positive on polarization (<xref ref-type="fig" rid="fig3">Figure 3</xref>). One of the cases had plant fiber in the bronchiole surrounded by neutrophils, which was diagnosed as aspiration pneumonia. Other abnormal findings consisted of lymphoid nodules in a three-year-old with COVID-19 and squamous metaplasia in a non-smoker decedent with COVID-19 (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><p>The pathology in the 22 negative cases had scattered pulmonary edema and congestion. Five cases had focal interstitial pneumonia with alveolar and bronchiolar damage. One case had granulomatous pneumonia with talc powder characterized by focal granulomas and multinucleated giant cells. The talc powder was positive on polarization. This case was deemed to be a chronic opioid user.</p><p>Of all 43 decedents, 11 had the cause of death as drug overdose (<xref ref-type="table" rid="table2"><xref ref-type="table" rid="table">Table </xref>2</xref>). 6 of these 11 were COVID-19 positive, and one case had granulomatous pneumonia with talc powder. The rest of the decedents were determined to have non-drug related causes of death (<xref ref-type="table" rid="table3"><xref ref-type="table" rid="table">Table </xref>3</xref>). Of these non-drug related deaths, 4 were found to have granulomatous pneumonia with talc powder. This is the first study that has a toxicology report with COVID-19 RT-PCR tests.</p></sec><sec id="s4"><title>4. Discussion</title><p>In this yearlong study, we enrolled all cases that were deemed COVID-19 suspicious. Twenty-one cases tested COVID-19 positive, and twenty-two cases tested COVID-19 negative.</p><p>The consistent pathology change seen in 21 COVID-19 positive decedents was a complete loss of bronchiolar respiratory epithelium and diffuse alveolar damage. These changes were seen in other published papers on COVID-19 lung pathology [<xref ref-type="bibr" rid="scirp.120683-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref18">18</xref>]. In addition to these two, there was severe pulmonary congestion, mild to severe peribronchiolar and perivascular lymphoid infiltration, and focal or multifocal interstitial pneumonia identified by alveolar wall thickening and lymphocytic infiltrate [<xref ref-type="bibr" rid="scirp.120683-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref18">18</xref>]. Four positive cases were diagnosed with hyaline membrane disease, and nine had micro thrombi formations [<xref ref-type="bibr" rid="scirp.120683-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref19">19</xref>].</p><p>Many of the negative cases were characterized by pulmonary edema and congestion. These are both signs of cardiovascular disease and respiratory illness. Of the seventeen non-drug related deaths that were COVID-19 negative, nine were found to have one of these as their cause of death.</p><p>Eleven cases had causes of death related to drug use based on a forensic toxicology screen. Of these, six cases were COVID-19 positive. Compared to the non-drug related death group, this shows an increasing percentage of COVID-19 positive decedents from 46.8% to 54.5%. This increase could be accounted for by increased person-to-person contact [<xref ref-type="bibr" rid="scirp.120683-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref12">12</xref>]. One of the six positive cases had granulomatous pneumonia with talc powder, which indicates inhalant use of opioids. In addition to this, 4 of the 32 cases with causes of death that were non-drug related had fluorescing talc powder. Out of these four, two died of granulomatous pneumonia with one being COVID-19 positive. These individuals did not have opioids in their system at their time of death, but the presence of talc powder indicates chronic inhalant use of opioids. Because of this lung damage caused by OUD, COVID-19 positive decedents would have an increased risk of death if they contracted the virus [<xref ref-type="bibr" rid="scirp.120683-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref13">13</xref>]. Of the remaining two, one died of hanging and the other had a history of depression. Mental illness is an indication of any pandemic but can be exacerbated in those affected by the opioid epidemic as well [<xref ref-type="bibr" rid="scirp.120683-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref14">14</xref>]. Finally, the Marion County Coroner’s Office’s 2019 and 2020 reports show an increase in drug overdoses from 24% to 39% of deaths or 406 to 640 deaths [<xref ref-type="bibr" rid="scirp.120683-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.120683-ref16">16</xref>].</p><p>Overall, approximately 34% of the decedents in this study had either a drug-related death or previous history of opioid use that can be confirmed. This and other statistics stated previously could indicate a greater risk of death during the pandemic for those with OUD overall [<xref ref-type="bibr" rid="scirp.120683-ref10">10</xref>] - [<xref ref-type="bibr" rid="scirp.120683-ref16">16</xref>].</p><p>Two limitations were identified for this study. The first was that many cases avoided the coroner’s office as hospital confirmed cases that died in the hospital and were sent directly to funeral homes. The second was that medical history could not be collected for many of the patients, due to the patient’s lack of a primary care physician.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The RT-PCR tests and histological analyses are consistent with the diagnosis of COVID-19 in 22 decedents. In addition, it was found that the COVID-19 pandemic could have multiple ways of exacerbating the opioid epidemic. These included mental health issues, increased social contact, and an increase in drug overdoses in the first year of the pandemic.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Bloom, A., Colter, A., Jacobsen, M., Battles, D., Alberston, T. and Sandusky, G. (2022) Pathological Lung Lesions of COVID-19 and Opioid Use Disorder: A Post-Mortem Lung and Toxicology Examination of 43 Decedents. Forensic Medicine and Anatomy Research, 10, 65-76. https://doi.org/10.4236/fmar.2022.104007</p></sec></body><back><ref-list><title>References</title><ref id="scirp.120683-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Tian, S., Xiong, Y., Liu, H., et al. (2020) Pathological Study of the 2019 Novel Coronavirus Disease (COVID-19) through Post-Mortem Core Biopsies. Modern Pathology. https://doi.org/10.20944/preprints202003.0311.v1</mixed-citation></ref><ref id="scirp.120683-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Fox, S., Akmatbekov, A., et al. (2020) Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans. MedRxiv. https://doi.org/10.1101/2020.04.06.20050575</mixed-citation></ref><ref id="scirp.120683-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Edler, C., Schroder, A.S., Aepfelbacher, M., et al. (2020) Dying with SARS-CoV-2 Infection—An Autopsy Study of the First Consecutive 80 Cases in Hamburg, Germany. International Journal of Legal Medicine, 134, 1275-1284. https://doi.org/10.1007/s00414-020-02317-w</mixed-citation></ref><ref id="scirp.120683-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Fox, S.E., Akmatbekov, A., Harbert, J.L., Li, G., Brown, J.Q. and Vander Heide, R.S. (2020) Pulmonary and Cardiac Pathology in African American Patients with COVID-19: An Autopsy Series from New Orleans. The Lancet Respiratory Medicine, 8, 681-686.</mixed-citation></ref><ref id="scirp.120683-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Wu, J.H., Li, X., Huang, B., et al. (2020) Pathological Changes of Fatal Coronavirus Disease 2019 (COVID-19) in the Lungs: Report of 10 Cases by Postmortem Needle Autopsy. Chinese Journal of Pathology, 49, 568-575.</mixed-citation></ref><ref id="scirp.120683-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Varga, Z., Flammer, A., et al. (2020) Endothelial Cell Infection and Endotheliitis in COIVD-19. The Lancet, 395, 1417-1418. https://doi.org/10.1016/S0140-6736(20)30937-5</mixed-citation></ref><ref id="scirp.120683-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Alanagreh, L., Alzoughool, F. and Atoum, M. (2020) The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms. Pathogens, 9, Article No. 331. https://doi.org/10.3390/pathogens9050331</mixed-citation></ref><ref id="scirp.120683-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Bourgonje, A., Abdulle, A.E., Timens, W., et al. (2019) Angiotensin-Converting Enzyme-2 (ACE2), SARS-CoV-2 and Pathophysiology of Coronavirus Disease 2019 (COVID-19). The Journal of Pathology, 251, 228-248.</mixed-citation></ref><ref id="scirp.120683-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Volkow, N.D. (2020) Collision of the COVID-19 and Addiction Epidemics. Annals of Internal Medicine, 173, 61-62. https://doi.org/10.7326/M20-1212</mixed-citation></ref><ref id="scirp.120683-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Mitchell, M., Shee, K., Champlin, K., Essary, A.C. and Evans, M. (2021) Opioid Use Disorder and COVID-19: Implications for Policy and Practice. JAAPA, 34, 1-4. https://doi.org/10.1097/01.JAA.0000742976.14811.36</mixed-citation></ref><ref id="scirp.120683-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Jenkins, W.D., Bolinski, R., Bresett, J., Van Ham, B., Fletcher, S., Walters, S., Friedman, S.R., Ezell, J.M., Pho, M., Schneider, J. and Ouellet, L. (2021) COVID-19 during the Opioid Epidemic—Exacerbation of Stigma and Vulnerabilities. The Journal of Rural Health, 37, 172-174. https://doi.org/10.1111/jrh.12442</mixed-citation></ref><ref id="scirp.120683-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Holland, K.M., Jones, C., Vivolo-Kantor, A.M., Idaikkadar, N., Zwald, M., Hoots, B., Yard, E., D’Inverno, A., Swedo, E., Chen, M.S., Petrosky, E., Board, A., Martinez, P., Stone, D.M., Law, R., Coletta, M.A., Adjemian, J., Thomas, C., Puddy, R.W., Peacock, G., Dowling, N.F. and Houry, D. (2021) Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes before and during the COVID-19 Pandemic. JAMA Psychiatry, 78, 372-379. https://doi.org/10.1001/jamapsychiatry.2020.4402</mixed-citation></ref><ref id="scirp.120683-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Khatri, U.G. and Perrone, J. (2020) Opioid Use Disorder and COVID-19: Crashing of the Crises. Journal of Addiction Medicine, 14, e6-e7. https://doi.org/10.1097/ADM.0000000000000684</mixed-citation></ref><ref id="scirp.120683-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Becker, W.C. and Fiellin, D.A. (2020) When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis. Annals of Internal Medicine, 173, 59-60. https://doi.org/10.7326/M20-1210</mixed-citation></ref><ref id="scirp.120683-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Marion County Coroner’s Office (2019) Marion County Coroner’s Office 2019 Annual Report. https://citybase-cms-prod.s3.amazonaws.com/ae291d010aa246119733a742dbfe6b48.pdf</mixed-citation></ref><ref id="scirp.120683-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Marion County Coroner’s Office (2020) Marion County Coroner’s Office 2020 Annual Report. https://media.graphassets.com/2u1y4IhNQBmQ8p1ssw2I</mixed-citation></ref><ref id="scirp.120683-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Aguiar, D., Lobrinus, J.A., Schibler, M., Fracasso, T. and Lardi, C. (2020) Inside the Lungs of COVID-19 Disease. International Journal of Legal Medicine, 134, 1271-1274. https://doi.org/10.21203/rs.3.rs-24321/v1</mixed-citation></ref><ref id="scirp.120683-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Tian, S., Weidong, H., et al. (2020) Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients with Lung Cancer. Journal of Thoracic Oncology, 15, 700-704. https://doi.org/10.1016/j.jtho.2020.02.010</mixed-citation></ref><ref id="scirp.120683-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Dolhnikoff, M., Duarte-Neto, A.N., et al. (2020) Pathological Evidence of Pulmonary Thrombotic Phenomena in Severe COVID-19. Journal of Thrombosis and Haemostasis, 18, 1517-1519. https://doi.org/10.1111/jth.14844</mixed-citation></ref></ref-list></back></article>